Home › Funds › Norris Financial Group, LLC › AUPH
Norris Financial Group, LLC position in AUPH
AURINIA PHARMACEUTICALS INC · Health Care
Norris Financial Group, LLC reported holding 358,042 shares of AUPH (AURINIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 3.44% of its reported portfolio and ranking #6 among its reported holdings. Norris Financial Group, LLC has disclosed AUPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Norris Financial Group, LLC's AUPH position evolved
Norris Financial Group, LLC first disclosed a stake in AUPH in Q3 2023 at 410,199 shares (US$3.2M). The position peaked in Q2 2026 at 342,331 shares, worth US$5.8M. Across 13 filings, Norris Financial Group, LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 358,042 shares valued at US$2.8M — an increase of 15,711 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 410.20K | $3.19M | New |
| Q4 2023 | 403.32K | $3.63M | Reduce |
| Q1 2024 | 434.83K | $2.18M | Add |
| Q2 2024 | 426.40K | $2.43M | Reduce |
| Q3 2024 | 417.51K | $3.06M | Reduce |
| Q4 2024 | 408.75K | $3.67M | Reduce |
| Q1 2025 | 387.84K | $3.12M | Reduce |
| Q2 2025 | 349.63K | $2.96M | Reduce |
| Q3 2025 | 344.87K | $3.81M | Reduce |
| Q4 2025 | 346.01K | $5.52M | Hold |
| Q1 2026 | 342.48K | $5.08M | Reduce |
| Q2 2026 | 342.33K | $5.81M | Hold |
| Q3 2026 | 358.04K | $2.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AUPH and 13F data
AUPH (AURINIA PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in AUPH — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$221.4M), NEA Management Company, LLC (US$67.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AUPH
- TANG CAPITAL MANAGEMENT LLC 13.04M sh · $221.36M · Q2 2026
- NEA Management Company, LLC 3.97M sh · $67.37M · Q2 2026
More on Norris Financial Group, LLC
FAQ
How long has Norris Financial Group, LLC held AUPH?
Norris Financial Group, LLC has disclosed AUPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Norris Financial Group, LLC's current position in AUPH?
As of Q3 2026, Norris Financial Group, LLC holds 358.04K shares of AUPH (AURINIA PHARMACEUTICALS INC), valued at $2.78M, representing 3.44% of its reported portfolio and ranking #6.
Has Norris Financial Group, LLC been buying or selling AUPH?
In the latest 13F filing (Q3 2026), Norris Financial Group, LLC increased its position in AUPH. The position peaked in Q2 2026 at 342.33K shares.
Which other funds hold AUPH?
Other major institutional holders of AUPH include TANG CAPITAL MANAGEMENT LLC, NEA Management Company, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.